Shopping Cart

No products in the cart.

AAMI TIR23 1999 RA 2019

$115.49

AAMI TIR23:1999/(R)2019 – Signal averaging

Published By Publication Date Number of Pages
AAMI 1999 38
Guaranteed Safe Checkout
Category:

If you have any questions, feel free to reach out to our online customer service team by clicking on the bottom right corner. We’re here to assist you 24/7.
Email:[email protected]

The signal-averaged electrocardiogram (SAECG) facilitates noninvasive recording of low-amplitude cardiac signals such as ventricular late potentials. The SAECG has been used to predict lifethreatening ventricular tachyarrhythmias in patients after acute myocardial infarction and with nonischemic dilated cardiomyopathy and to screen for inducible ventricular tachycardia in patients with unexplained syncope and with nonsustained ventricular tachycardia. This technical information report focuses on currently accepted methodology and clinical applications of the SAECG.

PDF Catalog

PDF Pages PDF Title
2 Blank Page
3 TIR23, Signal Averaging
4 Copyright Page
5 About AAMI Technical Information Reports
6 Table of Contents
8 Committee representation
9 1 Scope
2 Definitions
11 3 State of the art of current SAECG device design
3.1 Introduction
3.2 Architecture
12 3.3 Comparative table of specifications
13 3.4 Summary of beat alignment and measurement methods
4 Selection and alignment of normal sinus rhythm beats for ensemble averaging
4.1 Overview
4.2 Selecting a normal sinus rhythm beat as a “template”
14 4.3 Beat alignment techniques
4.4 Rejecting nonsinus rhythm beats
5 Ensemble averaging
5.1 Overview
15 5.2 Endpoint of signal averaging: quality control
5.3 Rejection of adversely noisy beats
6 SAECG analysis: digital filtering, lead combination, and measurements
6.1 Overview
16 6.2 Digital filtering schemes
6.3 Butterworth IIR filter, applied in a bidirectional mode
6.4 Spectral window filter
6.5 FIR filter
6.6 Lead combination: vector magnitude waveform
17 6.7 SAECG measurements of late potentials
7 Clinical applications of SAECG
7.1 SAECG methodology
19 7.2 Clinical application of the SAECG
7.2.1 Predischarge risk stratification after acute MI
20 7.2.2 Using the SAECG in combination with other noninvasive test results to predict serious ventricular arrhythmias after MI
21 7.2.3 Clinical limitations of the SAECG after MI
23 7.2.4 Interaction of invasive risk stratification with programmed ventricular stimulation and the SAECG
24 7.2.5 The clinical utility of the SAECG in the thrombolytic era
26 7.2.6 Prognostic value of the SAECG in patients with idiopathic dilated cardiomyopathy or with advanced heart failure
28 7.2.7 Predicting electrically induced ventricular tachycardia in the electrophysiology laboratory of patients with unexplained syncope
29 7.2.8 Predicting inducibility of sustained VT in patients with nonsustained VT
30 8 Emerging areas in signal-averaged ECG
8.1 Frequency domain analysis
8.2 P-wave signal-averaging and analysis methods
31 8.3 Application of P-SAECG to measurement of atrial activation
32 Annex A, Cited references
38 Annex B, Additional reading
AAMI TIR23 1999 RA 2019
$115.49